Total liabilities · 2011–2016

Bio-Techne total liabilities

$629M+127.1% · FY2016

Bio-Techne (TECH) reported $629M in total liabilities for fiscal 2016, +127.1% year on year.

$26.7M2011$30.0M2012$53.6M2013$298M2014$277M2015$629M2016
Bio-Techne — Total liabilities, 2011–2016
Fiscal yearTotal liabilitiesChangeFiling
FY20162016-12-31$629M+127.1%Open →Calculated
FY20152015-12-31$277M−7.1%Open →Calculated
FY20142014-12-31$298M+456.2%Open →Calculated
FY20132013-12-31$53.6M+78.8%Open →Calculated
FY20122012-12-31$30.0M+12.2%Open →Calculated
FY20112011-12-31$26.7M—Open →Calculated

Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2016 compound annual growth +88.1%

Total liabilities at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Bio-Techne total liabilities |url=https://companiesranked.com/en/company/bio-techne/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Bio-Techne total liabilities. CompaniesRanked. https://companiesranked.com/en/company/bio-techne/total-liabilities

BibTeX

@misc{companiesranked-en-company-bio-techne-total-liabilities-2026,
  author       = {{CompaniesRanked}},
  title        = {{Bio-Techne total liabilities}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/bio-techne/total-liabilities}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Bio-Techne overview